Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special Reports
The top 10 drugs losing US exclusivity in 2026
While megablockbusters naturally command significant attention, Fierce takes a chance each year to look at older medicines nearing their tumble over the patent cliff.
Eric Sagonowsky
,
Fraiser Kansteiner
,
Kevin Dunleavy
,
Zoey Becker
Mar 16, 2026 3:00am
Meds from Amgen, GSK now offered through TrumpRx DTC platform
Mar 16, 2026 11:33am
BioMarin halts dosing, enrollment in 3 midstage Voxzogo studies
Mar 16, 2026 11:26am
Idorsia shares sink after CEO's abrupt departure
Mar 16, 2026 11:00am
Lilly's Ebglyss scores eczema trial win in children
Mar 16, 2026 10:50am
J&J alleges trade secret theft by former staffer linked to Summit
Mar 16, 2026 10:44am
More News
Bayer tees up Kerendia for major CKD label expansion
Mar 16, 2026 9:46am
Regulatory tracker: AZ's Imfinzi scores EU label expansion
Mar 16, 2026 9:20am
Bayer found to have discredited industry after Roche row
Mar 13, 2026 11:45am
Pfizer CEO Albert Bourla earns 2025 pay bump to $27.6M
Mar 13, 2026 11:26am